Notably, only the IL-1 pathway seems to affect the phases preceding the respiratory function, nadir [38], such that early blockade of the IL-1 receptor (IL-1R) was effective in treating acute hyperinflammatory respiratory failure in COVID-19 patients [39,40,41,42,43,44]. The gene discussed is IL1R1; the disease is COVID-19.